annb0t
Top 20
SYDNEY, Jan. 16, 2023 /PRNewswire/ --Â Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce a placement of KZA shares, to institutional and sophisticated investors in Australia, at a price of A$0.11 per share. The placement will raise A$4.5 million (exclusive of costs). Kazia Therapeutics Limited Logo (PRNewsfoto/Kazia Therapeutics Limited)
Placement
The Placement to professional and sophisticated investors consists...
>>> Read more: KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS
Placement
The Placement to professional and sophisticated investors consists...
>>> Read more: KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS
